OppenheimerFunds’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $10.6M | Buy |
43,387
+941
| +2% | +$229K | 0.01% | 660 |
|
|
2018
Q4 | $8.09M | Buy |
42,446
+1,768
| +4% | +$337K | 0.01% | 684 |
|
|
2018
Q3 | $13.3M | Buy |
40,678
+2,029
| +5% | +$666K | 0.02% | 673 |
|
|
2018
Q2 | $12.1M | Buy |
38,649
+5,723
| +17% | +$1.79M | 0.01% | 685 |
|
|
2018
Q1 | $8.02M | Buy |
32,926
+244
| +0.7% | +$59.4K | 0.01% | 723 |
|
|
2017
Q4 | $9.87M | Buy |
32,682
+3,179
| +11% | +$960K | 0.01% | 736 |
|
|
2017
Q3 | $7.8M | Sell |
29,503
-1,181
| -4% | -$312K | 0.01% | 772 |
|
|
2017
Q2 | $8.09M | Buy |
30,684
+1,478
| +5% | +$389K | 0.01% | 777 |
|
|
2017
Q1 | $10.5M | Buy |
29,206
+678
| +2% | +$244K | 0.01% | 755 |
|
|
2016
Q4 | $8.23M | Buy |
28,528
+11,213
| +65% | +$3.23M | 0.01% | 781 |
|
|
2016
Q3 | $5.9M | Buy |
17,315
+6,024
| +53% | +$2.05M | 0.01% | 807 |
|
|
2016
Q2 | $4.8M | Buy |
11,291
+158
| +1% | +$67.1K | 0.01% | 807 |
|
|
2016
Q1 | $3.56M | Buy |
+11,133
| New | +$3.56M | ﹤0.01% | 836 |
|